BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8913537)

  • 21. Nitric oxide and the depressor response to angiotensin blockade in hypertension.
    Guan H; Cachofeiro V; Pucci ML; Kaminski PM; Wolin MS; Nasjletti A
    Hypertension; 1996 Jan; 27(1):19-24. PubMed ID: 8591882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of NO and angiotensin II in the early development of endothelial functions impairment and cardiac hypertrophy in deoxycorticosterone acetate-salt hypertension.
    K-Laflamme A; Oster L; Cardinal R; de Champlain J
    Can J Physiol Pharmacol; 1998 Jun; 76(6):665-75. PubMed ID: 9923405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AT2 antagonist-sensitive potentiation of angiotensin II-induced constriction by NO blockade and its dependence on endothelium and P450 eicosanoids in rat renal vasculature.
    Muller C; Endlich K; Helwig JJ
    Br J Pharmacol; 1998 Jul; 124(5):946-52. PubMed ID: 9692780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of bradykinins and nitric oxide in the AT2 receptor-mediated hypotension.
    Sosa-Canache B; Cierco M; Gutierrez CI; Israel A
    J Hum Hypertens; 2000 Apr; 14 Suppl 1():S40-6. PubMed ID: 10854080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin II receptors and renal hemodynamics and function.
    Ichikawa I
    Blood Press Suppl; 1996; 2():19-21. PubMed ID: 8913535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation by nitric oxide and prostaglandin of the renal vascular response to angiotensin II (3-8).
    Yoshida M; Kikukawa M; Hisa H; Satoh S
    Br J Pharmacol; 1996 Mar; 117(5):885-90. PubMed ID: 8851506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of losartan on renal microvasculature during chronic inhibition of nitric oxide visualized by micro-CT.
    Fortepiani LA; Ruiz MC; Passardi F; Bentley MD; Garcia-Estan J; Ritman EL; Romero JC
    Am J Physiol Renal Physiol; 2003 Nov; 285(5):F852-60. PubMed ID: 12837684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nitric oxide and prostaglandins in the prolonged effects of losartan and ramipril in hypertension.
    Cachofeiro V; Maeso R; Rodrigo E; Navarro J; Ruilope LM; Lahera V
    Hypertension; 1995 Aug; 26(2):236-43. PubMed ID: 7635531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contribution of nitric oxide to the acute antihypertensive effect of blockers of AT1 angiotensin receptors in spontaneously hypertensive rats.
    Cachofeiro V; Guan H; Nasjletti A
    Clin Exp Hypertens; 1997 Nov; 19(8):1247-61. PubMed ID: 9385474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The preclinical basis of the therapeutic evaluation of losartan.
    Timmermans PB; Wong PC; Chiu AT; Smith RD
    J Hypertens Suppl; 1995 Jul; 13(1):S1-13. PubMed ID: 18800450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Renal hemodynamic effect of angiotensin II type 2 receptor].
    Hamada K
    Nihon Jinzo Gakkai Shi; 2001; 43(1):28-34. PubMed ID: 11218315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin II AT1 receptor antagonists inhibit platelet adhesion and aggregation by nitric oxide release.
    Kalinowski L; Matys T; Chabielska E; Buczko W; Malinski T
    Hypertension; 2002 Oct; 40(4):521-7. PubMed ID: 12364357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hypertensive organ injuries in spontaneously hypertensive rats given N(G)-nitro-L-arginine methyl ester].
    Ishimitsu T; Ono H; Matsuoka H
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():278-83. PubMed ID: 16895196
    [No Abstract]   [Full Text] [Related]  

  • 34. Role of AT1 receptors in the renal papillary effects of acute and chronic nitric oxide inhibition.
    Ortíz MC; Fortepiani LA; Ruiz-Marcos FM; Atucha NM; García-Estañ J
    Am J Physiol; 1998 Mar; 274(3):R760-6. PubMed ID: 9580145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin AT(2) receptors mediate vasodepressor response to footshock in rats. Role of kinins, nitric oxide and prostaglandins.
    Israel A; Cierco M; Sosa B
    Eur J Pharmacol; 2000 Apr; 394(1):103-8. PubMed ID: 10771041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tonic stimulation of renin gene expression by nitric oxide is counteracted by tonic inhibition through angiotensin II.
    Schricker K; Hegyi I; Hamann M; Kaissling B; Kurtz A
    Proc Natl Acad Sci U S A; 1995 Aug; 92(17):8006-10. PubMed ID: 7644529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective role of the angiotensin AT2 receptor in a renal wrap hypertension model.
    Siragy HM; Carey RM
    Hypertension; 1999 May; 33(5):1237-42. PubMed ID: 10334818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sodium and angiotensin in hypertension induced by long-term nitric oxide blockade.
    Jover B; Herizi A; Ventre F; Dupont M; Mimran A
    Hypertension; 1993 Jun; 21(6 Pt 2):944-8. PubMed ID: 8505104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective effects of angiotensin AT1 receptor blockade in malignant hypertension in the rat.
    Therrien F; Lemieux P; Bélanger S; Agharazii M; Lebel M; Larivière R
    Eur J Pharmacol; 2009 Apr; 607(1-3):126-34. PubMed ID: 19326569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of active immunization against angiotensin AT1 or AT2 receptor on hypertension development in young and adult SHR.
    Zelezná B; Veselský L; Velek J; Dobesová Z; Zicha J; Kunes J
    Physiol Res; 1999; 48(4):259-65. PubMed ID: 10638677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.